Healthcare

Report by Aldis Institutional Services

2026 is shaping up to be an active year for US healthcare policy, with President Trump's focus on affordability impacting Congressional and Administration priorities. Near term, Congress is considering spending legislation impacting clinical labs (Quest Diagnostics, Labcorp), diagnostics (Natera) and life science tools (Danaher, Thermo Fisher). Investors are also awaiting clarity on MFN deals and their impact on companies that have not yet signed agreements with the Administration. Beyond HC, Aldis also leverages their connectivity to provide timely insights and updates around M&A with regulatory catalysts, including Nexstar-Tegna and Union Pacific-Norfolk Southern. Contact us below for further information on events hosted by Aldis and access to their content library.

Report by Insight Investment Research

Robert Crimes remains bullish on the Infrastructure sector, citing strong long-term traffic growth, resilient IRRs (averaging 11.3%, +290bps above Insight’s 8.5% Ke) and deep value in listed equities trading ~40% below NAV, despite private market transactions averaging just -3% below NAV over the past decade. Towers top the table with +136% weighted average upside, with Robert favouring Cellnex over Inwit. Railroads rank second at +113% average upside, favouring Canadian National Railway over Union Pacific and Canadian Pacific Kansas City. Contractors offer +74% upside, with Ferrovial standing out vs. Eiffage and Vinci. Airports offer +42% upside but stronger opportunities are seen in Europe with ADP, Aena and FH Zurich all offering 60%+ upside. In Toll Roads, average upside is only +19% but stock selection is key, with Salik Robert’s preferred pick.

Report by Off Wall Street

High and volatile inflation, historically, means wider swings in corporate profit margins. Uncertainty rises, companies stockpile more inventory, COGS is more volatile and difficult to manage. We saw this in the 1970s “stagflation”. US corporates are sitting on historically high profit margins today. Will that last? If it doesn’t, one potential source of short ideas are companies that have levered up their balance sheets against unsustainably high profit margins. These stocks wouldn’t look highly levered on a ND/EBITDA basis, but if profit margins start to revert lower, “normalised” leverage might be much higher than investors realise. Names of potential interest using OWS's short screener tool include Constellation Brands, Lincoln Electric, Parker-Hannifin, TransDigm and Union Pacific.

Industrials

Report by Paragon Intel

Paragon Intel is positive on UNP’s new external CEO, Jim Vena, who took the reins earlier this year after a 17-month search. They believe the industry veteran will surprise sceptics by balancing early gains in operating efficiencies with volume gains driven by better service in a tougher labour and regulatory environment. Paragon’s research includes interviews with Vena’s former colleagues who worked with him for more than 90 years combined - there was only one critic - who cautioned that he lacks experience dealing with US regulators.

Industrials

Report by Insight Investment Research

Robert Crimes initiates coverage with a Buy rating and TP of $384 (100% upside) - this follows Insight’s recent work on CN Rail (TP C$341, +120%) and CPKC (TP C$218, +108%). Railroads is now their preferred Infrastructure sub-sector, which is set to benefit from the “New Golden Age of Rail” driven by favourable environmental credentials and increasing cost advantage vs. road. While UNP has underperformed its peers regarding network fluidity, volumes, EBITDA growth and safety, Robert expects its new CEO to improve performance.

As infrastructure specialists, Insight focuses on lifetime free cash flows with detailed DCFs / DDMs and IRR-Ke valuations. Their CN Rail initiation report from earlier this year provides a useful example of a 'typical' Insight report and can be accessed by clicking here.